SOLESENCE, INC. — Director's Dealing 2007

Nov 7, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES CORPORATION (NANX)
CIK: 0000883107
Period of Report: 2007-11-06

Reporting Person: CROSS JOSEPH (Director, President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-11-06	Common Stock (right to buy)	$4.48	A	20000	Acquired	2017-11-06	Common Stock (20000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5638	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock (right to buy)	$2.9375	2008-11-09	Common Stock (100000)	100000	Direct
Common Stock (right to buy)	$7.6875	2010-05-24	Common Stock (100000)	100000	Direct
Common Stock (right to buy)	$10.875	2011-01-26	Common Stock (50000)	50000	Direct
Common Stock (right to buy)	$7.0625	2011-02-28	Common Stock (50000)	50000	Direct
Common Stock (right to buy)	$6.65	2012-01-03	Common Stock (55000)	55000	Direct
Common Stock (right to buy)	$3.66	2013-03-24	Common Stock (50000)	50000	Direct
Common Stock (right to buy)	$5.55	2014-10-11	Common Stock (15000)	15000	Direct
Common Stock (right to buy)	$6.03	2015-09-27	Common Stock (15000)	15000	Direct
Common Stock (right to buy)	$6.01	2016-09-27	Common Stock (20000)	20000	Direct
Common Stock (right to buy)	$2.1875	2009-01-04	Common Stock (50000)	50000	Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in five equal installments.

F2: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.